Meñoza, Ann-jelly .

HRN: 23-75-47  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2023
AMPICILLIN 1GM (VIAL)
09/29/2023
10/06/2023
IV
2gm
Q6
PROM X 8 Hours
Waiting Final Action 
09/30/2023
CEFUROXIME 500MG (TAB)
09/30/2023
10/07/2023
PO
500mg
BID X 7 Days
S/P NSVD With RMLE And Repair
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: